Co-Authors
This is a "connection" page, showing publications co-authored by Abdulkarim AbdulRahman and Stephen Atkin.
Connection Strength
0.919
-
Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain. Trop Dis Travel Med Vaccines. 2021 Jan 12; 7(1):1.
Score: 0.231
-
The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects. Int J Infect Dis. 2021 Jan; 102:285-288.
Score: 0.228
-
COVID-19 and sickle cell disease in Bahrain. Int J Infect Dis. 2020 Dec; 101:14-16.
Score: 0.226
-
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease. Sci Rep. 2021 05 11; 11(1):9927.
Score: 0.059
-
Time Till Viral Clearance of Severe Acute Respiratory Syndrome Coronavirus 2 Is Similar for Asymptomatic and Non-critically Symptomatic Individuals. Front Med (Lausanne). 2021; 8:616927.
Score: 0.059
-
The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes. Sci Rep. 2021 03 11; 11(1):5745.
Score: 0.058
-
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19. Int J Infect Dis. 2021 Apr; 105:656-661.
Score: 0.058